MIT duo wins Pritzker Prize for AI-discovered antibiotics

MIT researchers Regina Barzilay and James Collins are the 2026 recipients of the Pritzker Prize for AI in Science Research Excellence. The prize recognizes their joint work in AI-enabled antibiotic discovery, combining deep learning, bioengineering and experimental validation to identify new candidates against drug-resistant pathogens.

Barzilay is MIT's School of Engineering Distinguished Professor of AI and Health, and Collins is the Termeer Professor of Medical Engineering and Science. The two are faculty co-leads of the Abdul Latif Jameel Clinic for Machine Learning in Health (Jameel Clinic). Established in 2024 by the University of Chicago in partnership with Caltech, the prize carries $50,000 per award. It was the first time in the prize's history that a team was honored.

From halicin to abaucin

Their best-known breakthrough came in 2020, in a paper in Cell with Jonathan Stokes as first author: halicin, described as the first AI-discovered antibiotic. Named for the HAL 9000 system in 2001: A Space Odyssey, the molecule had originally been studied as a possible diabetes drug. A deep learning model trained on 2,500 molecules flagged it, and tests showed it killed resistant bacteria such as Clostridium difficile, Acinetobacter baumannii and Mycobacterium tuberculosis. A process that would have taken years was completed in a few weeks.

In 2023, the team used machine learning again to identify abaucin, a narrow-spectrum antibiotic effective against A. baumannii. Its precision is the point: by targeting a single species, abaucin lowers the chance of harming beneficial gut bacteria and driving resistance.

A project against seven deadly pathogens

Their current Antibiotics-AI Project, in partnership with the nonprofit Phare Bio, aims to develop seven new classes of antibiotics targeting seven of the world's deadliest bacterial pathogens. The University of Chicago cites a projection that antimicrobial resistance could cause 10 million deaths a year by 2050.

"Historically, antibiotic discovery has depended on laborious, trial-and-error strategies," Collins said. "With generative AI, we're now seeing a shift from AI being used as a tool for discovery to AI being used as a design tool." Barzilay cautioned that the field is still early: "With AI, we can only automate parts of the pipeline, rather than totally transforming the discovery process."

One clarification: alongside the MIT team, the University of Chicago also honored Kristin Persson of the University of California, Berkeley, for pioneering data-driven materials design and founding the Materials Project. Barzilay and Collins were therefore not the year's only recipients — they were its first winning team.

Image credit: official prize graphic released by the University of Chicago Data Science Institute.

Sources: MIT News and University of Chicago Data Science Institute.

Transparency: this article was produced with the assistance of artificial intelligence, cross-checked against public sources on the internet. Consult the original sources to confirm the details.

Muse